{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:13:25Z","timestamp":1768011205964,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T00:00:00Z","timestamp":1547596800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Novartis Farma","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12872-018-0986-y","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T08:02:58Z","timestamp":1547625778000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Morbidity and mortality in a population of patients affected by heart failure and chronic obstructive pulmonary disease: an observational study"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2979-783X","authenticated-orcid":false,"given":"Eugenio Roberto","family":"Cosentino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Landolfo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crescenzio","family":"Bentivenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Spinardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela Degli","family":"Esposti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arrigo Francesco","family":"Cicero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rinaldo","family":"Miceli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virna","family":"Bui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Berardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,16]]},"reference":[{"key":"986_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/resp.12660","volume":"21","author":"JL Lopez-Campos","year":"2016","unstructured":"Lopez-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016;21:14\u201323.","journal-title":"Respirology"},{"key":"986_CR2","unstructured":"Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017. Available from: \n                    http:\/\/goldcopd.org\n                    \n                  ."},{"issue":"2","key":"986_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/1479972316674393","volume":"14","author":"R Pavasini","year":"2017","unstructured":"Pavasini R, Tavazzi G, Biscaglia S, Guerra F, Pecoraro A, Zaraket F, et al. Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis. Chron Respir Dis. 2017;14(2):117\u20136.","journal-title":"Chron Respir Dis"},{"issue":"1","key":"986_CR4","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1183\/09031936.06.00024505","volume":"27","author":"KR Chapman","year":"2006","unstructured":"Chapman KR, Mannino DM, Soriano JB, Vermeire PA, Buist AS, Thun MJ, et al. Epidemiology and costs of chronic obstructive pulmonary disease. EurRespir J. 2006;27(1):188\u2013207.","journal-title":"EurRespir J"},{"issue":"4","key":"986_CR5","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0002-9149(00)01393-X","volume":"87","author":"DW Kitzman","year":"2001","unstructured":"Kitzman DW, Gardin JM, Gottdiener JS, Arnold A, Boineau R, Aurigemma G, et al. Cardiovascular health study research group. Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS research group. Cardiovascular health study. Am J Cardiol. 2001;87(4):413\u20139.","journal-title":"Am J Cardiol"},{"issue":"1","key":"986_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/ejhf.964","volume":"20","author":"M Canepa","year":"2018","unstructured":"Canepa M, Straburzynska-Migaj E, Drozdz J, Fernandez-Vivancos C, Fernandez-Vivancos C, Pinilla JMG, Nyolczas N, et al. ESC-HFA heart failure long-term registry investigators. Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry. Eur J Heart Fail. 2018;20(1):100\u201310.","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"986_CR7","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/eurjhf\/hfn013","volume":"11","author":"NM Hawkins","year":"2009","unstructured":"Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG, McMurray JJ. Heart failure and chronic obstructive pulmonarydisease: diagnostic pitfalls and epidemiology. Eur J Heart Fail. 2009;11(2):130\u20139.","journal-title":"Eur J Heart Fail"},{"issue":"19","key":"986_CR8","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.ehj.2004.07.007","volume":"25","author":"F Gustafsson","year":"2004","unstructured":"Gustafsson F, Torp-Pedersen C, Seibaek M, Burchardt H. K\u00f8berL, DIAMOND study group. Effect of age on short and long-term mortality in patients admitted to hospital with congestive heart failure. Eur Heart J. 2004;25(19):1711\u20137.","journal-title":"Eur Heart J"},{"issue":"1 Pt 1","key":"986_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0002-8703(00)90313-2","volume":"139","author":"G Gambassi","year":"2000","unstructured":"Gambassi G, Forman DE, Lapane KL, Mor V, Sgadari A, Lipsitz LA, et al. Management of heart failure among very old personsliving in long-term care: has the voice of trials spread? The 3SAGE study group. Am Heart J. 2000;139(1 Pt 1):85\u201393.","journal-title":"Am Heart J"},{"key":"986_CR10","doi-asserted-by":"crossref","unstructured":"Havranek EP, Masoudi FA, Westfall KA, Wolfe P, Ordin DL, Krumholz HM. Spectrum of heart failure in older patients: results from the National Heart Failure project. Am Heart J2002;143(3):412\u20147.","DOI":"10.1067\/mhj.2002.120773"},{"issue":"9","key":"986_CR11","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.ejheart.2007.06.004","volume":"9","author":"A Macchia","year":"2007","unstructured":"Macchia A, Monte S, Romero M, D\u2019Ettorre A, Tognoni G. The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure. Eur J Heart Fail. 2007;9(9):942\u20138.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"986_CR12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1056\/NEJMoa051530","volume":"355","author":"RS Bhatia","year":"2006","unstructured":"Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006;355(3):260\u20139.","journal-title":"N Engl J Med"},{"key":"986_CR13","doi-asserted-by":"crossref","unstructured":"Rutten FH, Cramer MJ, Grobbee DE, Sachs AP, Kirkels JH, Lammers JW, et al. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 2005;26(18):1887\u201494.","DOI":"10.1093\/eurheartj\/ehi291"},{"issue":"3","key":"986_CR14","first-page":"198","volume":"10","author":"PA McCullough","year":"2003","unstructured":"McCullough PA, Hollander JE, Nowak RM, Storrow AB, Duc P, Omland T, et al. BNP Multinational Study Investigators. Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. AcadEmerg Med. 2003;10(3):198\u2013204.","journal-title":"AcadEmerg Med"},{"issue":"7","key":"986_CR15","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.ejheart.2006.01.010","volume":"8","author":"FH Rutten","year":"2006","unstructured":"Rutten FH, Cramer MJ, Lammers JW, Grobbee DE, Hoes AW. Heart failure and chronic obstructive pulmonary disease: an ignored combination? Eur J HeartFail. 2006;8(7):706\u201311.","journal-title":"Eur J HeartFail"},{"issue":"6","key":"986_CR16","first-page":"1157","volume":"29","author":"G Testa","year":"2017","unstructured":"Testa G, Cacciatore F, Bianco A, Della-Morte D, Mazzella F, Galizia G, et al. Chronic obstructive pulmonary disease and long-term mortality in elderly subjects with chronic heart failure. AgingClinExp Res. 2017;29(6):1157\u201364.","journal-title":"AgingClinExp Res"},{"key":"986_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.rmed.2017.07.059","volume":"131","author":"P Pirina","year":"2017","unstructured":"Pirina P, Martinetti M, Spada C, Zinellu E, Pes R, Chessa E, COPD-HF Study Group, et al. PrevalenceandmanagementofCOPDandheart failurecomorbidityin thegeneral practitionersetting. Respir Med. 2017;131:1\u20135.","journal-title":"Respir Med"},{"key":"986_CR18","doi-asserted-by":"crossref","unstructured":"Cosentino ER, Esposti DD, Miceli R, Bentivenga C, Landolfo M, Iamino IR, Magri G, Borghi C. Co-existing diseases: heart failure and COPD. Report of two cases treated with indacatrol\/glycopirronium. Respiration 2018, paper accepted.","DOI":"10.1159\/000487169"},{"issue":"2","key":"986_CR19","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1124\/jpet.112.194456","volume":"343","author":"DA Sykes","year":"2012","unstructured":"Sykes DA, Dowling MR, Leighton-Davies J, Kent TC, Fawcett L, Renard E, et al. The influence of receptor kinetics on the onset and duration of action and the therapeutic index of NVA237 and tiotropium. J Pharmacol Exp Ther. 2012;343(2):520\u20138.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"986_CR20","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1183\/09031936.00032806","volume":"29","author":"E Naline","year":"2007","unstructured":"Naline E, Trifilieff A, Fairhurst RA, Advenier C, Molimard M. Effect of indacaterol, a novel long-acting beta2-agonist, on isolated human bronchi. Eur Respir J. 2007;29(3):575\u201381.","journal-title":"Eur Respir J"},{"issue":"4","key":"986_CR21","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1093\/ejechocard\/jen174","volume":"9","author":"A Evangelista","year":"2008","unstructured":"Evangelista A, Flachskampf F, Lancellotti P, Badano L, Aguilar R, Monaghan M, et al. On behalf of the European Association of Echocardiography. European Association of Echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studies. Eur J Echocardiogr. 2008;9(4):438\u201348.","journal-title":"Eur J Echocardiogr"},{"key":"986_CR22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1471-2466-11-42","volume":"11","author":"PW Jones","year":"2011","unstructured":"Jones PW, Tabberer M, Chen WH. Creating scenarios of the impact of COPD and their relationship to COPD assessment test (CAT\u2122) scores. BMC Pulm Med. 2011;11:42.","journal-title":"BMC Pulm Med"},{"issue":"3","key":"986_CR23","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1183\/09031936.00102509","volume":"34","author":"PW Jones","year":"2009","unstructured":"Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648\u201354.","journal-title":"Eur Respir J"},{"issue":"10","key":"986_CR24","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa021322","volume":"350","author":"BR Celli","year":"2004","unstructured":"Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005\u201312.","journal-title":"N Engl J Med"},{"key":"986_CR25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ejim.2017.08.016","volume":"47","author":"M Contoli","year":"2018","unstructured":"Contoli M, Campo G, Pavasini R, Marchi I, Pauletti A, Balla C, et al. Inhaled corticosteroid\/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients. Eur J Intern Med. 2018;47:82\u20136.","journal-title":"Eur J Intern Med"},{"issue":"3","key":"986_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1056\/NEJMoa0808836","volume":"362","author":"RG Barr","year":"2010","unstructured":"Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, Hoffman EA, et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med. 2010;362(3):217\u201327.","journal-title":"N Engl J Med"},{"issue":"1","key":"986_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1378\/chest.09-2810","volume":"138","author":"H Watz","year":"2010","unstructured":"Watz H, Waschki B, Meyer T, Kretschmar G, Kirsten A, Claussen M, Magnussen H. Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. Chest. 2010;138(1):32\u20138.","journal-title":"Chest"},{"issue":"7","key":"986_CR28","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1164\/rccm.201508-1647OC","volume":"193","author":"IS Stone","year":"2016","unstructured":"Stone IS, Barnes NC, James W-Y, Midwinter D, Boubertakh R, Follows R, et al. Lung deflation and cardiovascular structure and function in chronic obstructive pulmonary disease. A randomized controlled trial. Am J Respir Crit Care Med. 2016;193(7):717\u201326.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"986_CR29","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S2213-2600(18)30054-7","volume":"6","author":"JM Hohlfeld","year":"2018","unstructured":"Hohlfeld JM, Vogel-Claussen J, Biller H, Berliner D, Berschneider K, Tillmann HC, et al. Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): a double-blind, randomised, crossover, placebo-controlled, single-Centre trial. Lancet RespirMed. 2018;6(5):368\u201378.","journal-title":"Lancet RespirMed"},{"issue":"4","key":"986_CR30","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1183\/09031936.00180812","volume":"41","author":"B Begh\u00e9","year":"2013","unstructured":"Begh\u00e9 B, Verduri A, Roca M, Fabbri LM. Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD. Eur Respir J. 2013;41(4):993\u20135.","journal-title":"Eur Respir J"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-018-0986-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-018-0986-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-018-0986-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T19:10:42Z","timestamp":1579115442000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-018-0986-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,16]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["986"],"URL":"https:\/\/doi.org\/10.1186\/s12872-018-0986-y","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,16]]},"assertion":[{"value":"27 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Yes. Informed, written consent was obtained from all participants. The study was evaluated by the ethical board of the S. Orsola-Malpighi University Hospital.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Yes","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"20"}}